Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates

Arthritis and Rheumatism
Edward YelinCharles G Helmick

Abstract

To provide estimates of the total medical care expenditures and earnings losses associated with arthritis and other rheumatic conditions (AORC), as well as the increment in such costs specifically attributable to these conditions, in the US in 1997. The estimates were derived from the 1997 Medical Expenditures Panel Survey (MEPS), a national probability sample of 14,147 households including 34,551 persons, of whom 4,776 self-reported arthritis. After weighting, those who self-reported AORC represent 38.4 million persons. We tabulated all medical care expenditures of the adult MEPS respondents, stratified by arthritis and comorbidity status, and then used regression techniques to estimate the increment in health care expenditures attributable to AORC, after taking comorbidity, demographic characteristics, and insurance status into account. Using the same methods, we also estimated the magnitude of the earnings losses sustained by persons of working ages (18-64 years) who had AORC. Persons with AORC incurred mean total medical care expenditures of 4,865 dollars (total 186.9 billion dollars). The largest components of these expenditures were inpatient care (39%), ambulatory care (29%), and prescriptions (14%). The mean increment i...Continue Reading

References

Jan 1, 1990·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·B S Webster, S H Snook
May 1, 1987·Arthritis and Rheumatism·E YelinW Epstein
Jan 1, 1984·Medical Decision Making : an International Journal of the Society for Medical Decision Making·M S ThompsonM Liang
May 1, 1984·Arthritis and Rheumatism·M H LiangJ Taylor
Jan 1, 1993·Scandinavian Journal of Rheumatology·K EberhardtK Nived
Mar 1, 1997·Current Opinion in Rheumatology·O Sangha, G Stucki
Apr 1, 1997·Seminars in Arthritis and Rheumatism·J RothfussM H Brenner
Jun 1, 1997·Clinical Rheumatology·K L ReschE Ernst
Jan 16, 1998·Baillière's Clinical Rheumatology·L M March, C J Bachmeier
Mar 26, 1998·The American Journal of Drug and Alcohol Abuse·J E Kallan
Sep 12, 1998·British Journal of Rheumatology·C H van JaarsveldJ W Bijlsma
Nov 4, 1994·PharmacoEconomics·S H AllaireR F Meenan
Mar 17, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J A AstinW L Haskell
Feb 13, 2003·Arthritis and Rheumatism·Dorothy D DunlopRowland W Chang

❮ Previous
Next ❯

Citations

Jun 13, 2006·Disease Management : DM·Wayne N BurtonDee W Edington
Mar 15, 2006·Annual Review of Public Health·Alicia L CarbaughDiane Rowland
May 28, 2010·BMC Musculoskeletal Disorders·Ioannis AnagnostopoulosLazaros I Sakkas
Oct 3, 2009·The Journal of Rheumatology·Miriam G CisternasCharles G Helmick
May 31, 2008·American Journal of Public Health·Tricia J Johnson, Stephanie Stahl-Moncada
Oct 22, 2011·Journal of Occupational and Environmental Medicine·Ariel BergerGerry Oster
Jan 10, 2012·Journal of Occupational and Environmental Medicine·W Robert SimonsDigisha N Trivedi
Nov 23, 2013·Modern Rheumatology·Berat Meryem AlkanOzge Ardıçoğlu
Dec 22, 2015·Autoimmunity Reviews·Marvin J Fritzler
Aug 8, 2012·Best Practice & Research. Clinical Rheumatology·Monique A M GignacElizabeth M Badley
Jan 31, 2015·European Journal of Public Health·Pedro A LairesMiguel Gouveia
May 1, 2009·Arthritis and Rheumatism·Simone AppenzellerLilian T L Costallat
Jan 11, 2008·Journal of the American Geriatrics Society·Kenneth E CovinskyEdward Yelin
Dec 23, 2011·The Milbank Quarterly·J Paul Leigh
Apr 22, 2006·American Journal of Preventive Medicine·Margaret ShihCharles G Helmick
Mar 21, 2006·Best Practice & Research. Clinical Rheumatology·Kirsten Minden
Feb 8, 2006·Journal of Manipulative and Physiological Therapeutics·Jerrilyn Cambron, Toby King
Apr 17, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Feng XieShu-Chuen Li
Jun 9, 2009·BMC Musculoskeletal Disorders·Jeffrey N KatzElena Losina
May 14, 2011·International Journal of Health Services : Planning, Administration, Evaluation·Thomas A LaVeistPatrick Richard
Mar 22, 2007·Physical Therapy·Stephanie K Carter, John A Rizzo
May 24, 2016·Arthritis Care & Research·Louise B MurphyCharles G Helmick
Sep 28, 2017·Arthritis Care & Research·Louise B MurphyEdward H Yelin
Feb 3, 2007·Arthritis and Rheumatism·Edward YelinPeter Panopalis
Dec 1, 2007·Arthritis and Rheumatism·Pantelis PanopalisEdward Yelin
Oct 7, 2005·Arthritis and Rheumatism·Judith A RicciMarc C Hochberg
Apr 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Dean A RegierCarlo A Marra
Apr 26, 2007·American Journal of Physiology. Endocrinology and Metabolism·K E Scholz-AhrensC-C Glüer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Arthritis and Rheumatism
Dorothy D DunlopRowland W Chang
Australian and New Zealand Journal of Medicine
M J AhernM Clark
The British Journal of Psychiatry : the Journal of Mental Science
J C Rigby, A G Oswald
© 2022 Meta ULC. All rights reserved